CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,021,538
+$3,066,011 QoQ
Shares Held
725,030
+1.2% QoQ
Ownership
0.651%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 207 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. AMLX ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in AMLX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,021,538 | 725,030 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,955,527 | 716,225 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,612,919 | 712,990 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,768,064 | 645,185 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,771,714 | 588,411 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,319,899 | 372,853 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,130,027 | 298,949 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $979,354 | 302,270 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $991,076 | 521,619 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,237,964 | 435,903 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,705,766 | 387,620 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,698,933 | 365,862 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,020,646 | 325,482 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,391,323 | 320,086 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,739,717 | 317,719 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,776,802 | 240,739 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,356,077 | 70,409 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $938,396 | 73,027 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||